Small-cell lung cancer spreads quickly. From 67%-75% of people who develop small cell lung cancerwill have spread the SCLC outside of the lung to other parts of the body at the time of initial diagnosis. Small-cell lung cancer responds well to chemotherapy (using medications to kill cancer...
Five-year survival rates remain at less than 10%. However, there has been some progress in the therapy of one histological subtype of lung cancer, small cell lung cancer. Totaling around 20% of lung cancer cases, small cell lung cancer is distinct from the other histologic subtypes in its ...
British Journal of CancerGROSCLAUDE, P., GALAT, J.P., MACE´-LESECH, J., ROUMAGNAC-MACHELARD, M., MERCIER, M. and ROBILLARD, J., Differences in treatment and survival rates of non-small-cell lung cancer in three regions of France. Brit. J. Cancer, 72, 1278-1282 (1995)....
BACKGROUND: Small cell lung cancer (SCLC) is an extremely aggressive tumor with a poor clinical course. Although many efforts have been made to improve patients' survival rates, patients who survive longer than 2 years after chemotherapy are still very rare. We examined the baseline characteristics...
The CREST study showed that the addition of thoracic radiotherapy (TRT) could improve the survival rate in patients with extensive stage small cell lung cancer (ES-SCLC), but whether TRT can bring survival benefit in the era of immunotherapy remains controversial. This study aimed to explore the...
Small cell lung cancer is characterized by early metastases and rapid growth. While initially very responsive to both chemotherapy and radiation therapy, the majority of patients will have recurrent disease or become refractory to treatment. The 5-year survival of patients with small cell lung ...
Prolonged Survival of Patients With Non–Small-Cell Lung Cancer With Leptomeningeal Carcinomatosis in the Modern Treatment Era Prolonged survival of patients with non-small-cell lung cancer with leptomeningeal carcinomatosis in the modern treatment era[J]. Clin Lung Cancer May, ... JW Riess,S ...
Study Finds Declining SCLC Incidence, but Stagnant Survival Rates ByHayden E. Klein SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more effective treat...
The short term effects of the two groups were observed and then we analyzed the 1, 2, 3 year over survival rates of the cases in localized stage and in extensive stage. [Results] The response rates of the EP group and the Paclitaxel group were 88%, and 91.7% separately. There was no...
Long term survival in small cell lung cancer (SCLC) patients: A French prospective study : P. Jacoulet, A. Depierre, E. Quoix, D. Moro, E. Ranfaing, B. Lebeau, A. Rivière, B. Milleron, F. Capron, D. Anthoine, G. Miech, and the Groupe d'Oncologie de Langue Française. ...